 Failure Hancock pericardial xenografts prophylactic bioprosthetic replacement incidence major valve-related complications series patients Hancock pericardial xenograft aortic AVR mitral MVR mitral-aortic MAVR replacement years actuarial survival AVR MVR MAVR whereas actuarial freedom valve-related death AVR MVR MAVR Actuarial freedom thromboemboli anticoagulant-related hemorrhage years AVR MVR complications MAVR Structural valve deterioration reoperation autopsy clinical investigation patients AVR /patient-year MVR /patient-year MAVR /patient-year AVR patients underwent reoperation reoperation patients MVR underwent reoperation patients MAVR underwent reoperation reoperation Seventy-eight percent current survivors patients AVR MVR MAVR clinical evidence valve failure years actuarial freedom structural deterioration Hancock pericardial xenograft AVR MVR MAVR